Shockwave Medical (NSDQ:SWAV) this week posted first-quarter results that beat the overall consensus on Wall Street. The Santa Clara, California-based company reported profits of $14.5 million, or 39¢ per share, on sales of $93.6 million for the three months ended March 31, for a bottom-line gain from the year prior on sales growth of 193.5%. Earnings […]
Shockwave Medical
Shockwave Medical up on 270% sales growth in Q4
Shockwave Medical (NSDQ:SWAV) posted fourth-quarter results that beat the overall consensus on Wall Street. The Santa Clara, California-based company has proprietary cardiovascular disease treatment tech involving local delivery of sonic pressure. Yesterday evening it reported profits of $12.9 million, or 34¢ per share, on sales of $84.2 million for the three months ended Dec. 31, […]
Shockwave Medical rises on Street-beating Q2, raised guidance
Shockwave Medical (NSDQ:SWAV) shares ticked up today on second-quarter results that topped the consensus forecast. The Santa Clara, Calif.–based company posted losses of -$425,000 on sales of $55.9 million for the three months ended June 30, 2021, for a 97.7% bottom-line gain thanks to the company’s revenues multiplying by more than five times year-over-year. Earnings […]
Shockwave Medical stock up nearly 21%
Shockwave Medical (NSDQ:SWAV) posted first-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. Shockwave Medical, though, also said it projects revenue for the full year to roughly triple to between $195–205 million — representing 188–202% growth over the prior year’s revenue. The Santa Clara, Calif.-based company — which has proprietary cardiovascular […]
This telemedicine system could get medtech sales reps back to ORs
Daniel Hawkins’ surprise isn’t a matter of what, but when. The successful medtech executive and former Shockwave Medical CEO fully expected medical device makers would see Avail Medsystem’s telemedicine system as a more efficient way for sales reps to sit in on surgeries. By Hawkins’ projections, Avail’s system would eliminate much of the time sales […]
Shockwave ticks up on Street-beating Q2
Shockwave Medical (NSDQ:SWAV) shares got a slight boost today on second-quarter results that topped the consensus forecast. The Santa Clara, Calif.-based calcified coronary lesions treatment developer posted losses of -$18.1 million, or -56¢ per share, on sales of $10.3 million for the three months ended June 30, 2020, for a -70.8% bottom-line slide on sales growth […]
COVID-19 upends medtech’s financial outlook
The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]
These young medtech companies raised the most money in 2019
Medical device industry insiders may very well remember 2019 as the year that IPOs came back — but another sign that the U.S. economy has left the Great Recession far behind. Among the top investment deals in the space, half involved public offerings, according to the MoneyTree report from PricewaterhouseCoopers (PwC) and CB Insights. Total investments […]
Shockwave Medical prices $75 million offering
Shockwave Medical (NSDQ:SWAV) filed a common stock equity offering with the SEC priced at $75 million. The Santa Clara, Calif.–based company said in yesterday’s filing that at the assumed public offering price of $36.14 that was reported on Nov. 11, it expects to offer nearly 2.1 million shares of common stock. Shockwave said it anticipates approximately […]
FDA grants Shockwave Medical breakthrough device label
Shockwave Medical (NSDQ:SWAV) has won breakthrough device designation from the FDA for the sonic pressure-wave system it has developed to treat calcified coronary lesions. The Santa Clara, Calif.-based company’s C2 IVL (intravascular lithotripsy) catheter is designed to improve blood flow to the heart by fracturing problematic calcium using sonic pressure waves to enable stent delivery, deployment […]
Abiomed’s stake in Shockwave is worth at least $58m
The $10 million Abiomed (NSDQ:ABMD) put into Shockwave Medical (NSDQ:SWAV) has paid off so far no matter how you slice it. Shockwave raised nearly $97 million in an initial public offering earlier this month, inking a private-placement deal with Abiomed on the side for $10.0 million worth of SWAV shares at the $17-per-share IPO price. […]
